Insider · CIK 0001418881

Christianson Gary

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001418881

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−68K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−15K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−165K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−11.3K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.U Disposition from Tender	Chief Operating Officer	UDisposition from Tender	−6,515 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−8,334 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−8,334 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−8,334 sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−25K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−16.7K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−41.7K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−41.7K sh	—	—	0
2018-03-09	Cascadian Therapeutics, Inc.Stock Option (Right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−51.2K sh	—	—	0
2018-02-01	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Chief Operating Officer	AAward	+165K sh	—	—	164,500
2018-01-11	Cascadian Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,825 sh	—	—	7,438
2018-01-11	Cascadian Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−923 sh	$3.92	−$3,618.16	6,515
2018-01-11	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,825 sh	—	—	8,475
2017-09-18	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+68K sh	—	—	68,000
2017-09-18	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Chief Operating Officer	AAward	+15K sh	—	—	15,000
2017-01-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+51.2K sh	—	—	51,200
2017-01-11	Cascadian Therapeutics, Inc.Restricted Share Unit (RSU)A Award	Chief Operating Officer	AAward	+11.3K sh	—	—	11,300
2016-05-17	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+250K sh	—	—	250,000
2015-09-24	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+250K sh	—	—	250,000
2014-12-16	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000
2013-12-12	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+150K sh	—	—	150,000
2012-12-12	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2011-12-01	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2010-12-01	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2010-12-01	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000
2009-12-03	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000
2009-03-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+30K sh	—	—	30,000
2009-03-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Mar 134
Christianson Gary0000899243-18-007294
SEC(opens sec.gov)
Feb 24
Christianson Gary0001209191-18-007131
SEC(opens sec.gov)
Jan 164
Christianson Gary0001209191-18-003644
SEC(opens sec.gov)
Sep 204
Christianson Gary0001209191-17-053536
SEC(opens sec.gov)
Jan 134
Cascadian Therapeutics, Inc.0001209191-17-003755
SEC(opens sec.gov)

Companies

Cascadian Therapeutics, Inc.Chief Operating Officer

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121